Daidzein and its metabolite equol strongly inhibited the activity of breast cancer resistance protein (BCRP) and, thus, enhanced the chemosensitivity of breast cancer cells towards BCRP substrates 194. The gene discussed is ABCG2; the disease is breast carcinoma.